by David Eyre | Feb 28, 2023 | UK
In this decision the Hearing Officer noted that a marketing authorisation is focused on what a product is rather than what it does. Consequently, a change in how the authorised product is used does not alter the basis of the original marketing authorisation....
by Sean Hutchinson | Feb 20, 2023 | EPO, UPC
We reported in our article of December 2022 that the start date of the Unified Patent Court (“UPC”) had been delayed yet again, this time in view of some difficulties many users were having with acquiring the authentication devices required to access the UPC’s Case...
by Eddie Bishop | Feb 3, 2023 | EPO
Background Historically (pre-2019), a subrange was considered novel over the prior art if the following criteria were met (T198/84 and T279/89): a) The selected subrange is narrower than the known range; b) The selected subrange is sufficiently far removed from any...
by Carolyn Haywood | Jan 11, 2023 | EPO
Timeline of events The applicant filed a Petition for Review against the ‘decision’ of the Board of Appeal in T 0695/18 of 5 October 2021 not to consider their submissions of 29 September and 5 October 2021 respectively. The Petition for Review was based on (i)...
by Sean Hutchinson | Dec 22, 2022 | EPO
Background In 2019, the European Patent Office (EPO) set out its Strategic Plan 2023, detailing a series of proposed updates and reforms to its working practices, including changes to its IT systems. At that time, nobody could have predicted just how quickly the EPO...
by Sean Hutchinson | Dec 21, 2022 | EPO
The EPO’s longstanding requirement for applicants of European patent applications to amend the description to bring this into conformity with the allowed claims before the EPO will grant a patent on the application has been the subject of much scrutiny over the last...
Recent Comments